CD&R

McKesson and private equity firm Clayton, Dubilier & Rice are taking home infusion therapy provider Option Care Health private in a deal valued at $5.8 billion. The move gives McKesson full ownership of the infusion business, one of the largest providers of home and alternative site infusion services in the United States.

Private equity firm Clayton, Dubilier & Rice and healthcare distributor McKesson have agreed to acquire an at-home infusion therapy provider in a deal valued at $5.8 billion, according to the Wall Street Journal. The acquisition highlights continued investor interest in home-based healthcare services, a fast-growing segment as more patients receive intravenous treatments outside hospitals.

Private equity firm Clayton, Dubilier & Rice and healthcare distributor McKesson have agreed to acquire an at-home infusion therapy provider in a deal valued at $5.8 billion. The acquisition underscores continued investor interest in home-based healthcare services, a segment growing as more patients receive complex treatments like infusion therapy outside hospitals.

McKesson and private equity firm Clayton, Dubilier & Rice are reportedly in talks to acquire Option Care Health, the US home infusion services provider, in a deal valued at more than $5 billion. The move would deepen McKesson's push into home-based healthcare delivery. Market watchers are weighing what the takeover would mean for competition in the fast-growing home infusion sector.